Supporting TB recovery: The UPLIFT trial
Part of Infections clinical trials.
This trial is studying if offering extra support to people being treated for tuberculosis (TB) can help them recover and feel better overall. It's for people who have started treatment for drug-sensitive TB and live in certain areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with TB that is not resistant to drugs and it affects your lungs.
- This is your first time being treated for TB or you have had TB before and it has come back (relapse).
- You have started TB treatment and your case has been officially reported in the VITIMES system.
- You have been living in one of the study districts for at least the past month.
- You are the first person in your household to join this study.
- You are not planning to move to a different area in the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital support program to reduce stigma and improve health outcomes for people with active tuberculosis. It uses online tools and questionnaires, and may help you feel less isolated and better manage your TB treatment.
This study is collecting information from people who are starting TB treatment to learn more about how well the treatment works. The goal is to better understand factors that influence TB treatment success.
This trial tests a special nursing care program for people with tuberculosis. It aims to improve how care is given at the hospital and at home, possibly making treatment easier to follow and more supportive.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
This trial studies whether reminder-based “vDOT” and small economic incentives can help people complete treatment for latent (sleeping) tuberculosis. If you have latent TB and are starting a standard medicine plan, it may help you stay on track and finish safely.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.